The Dark Side of Wall Street: Young Bankers’ Desperate Reliance on ADHD Drugs
In a shocking exposé that pulls back the curtain on Wall Street’s grueling work environment, young financial professionals are turning to prescription stimulants to survive punishing work schedules that can extend beyond 22 hours a day.
A culture of extreme overwork
The Wall Street Journal has uncovered a disturbing trend among young bankers who are increasingly using prescription ADHD medications like Adderall and Vyvanse to manage impossible workloads. The industry’s culture of extreme dedication has created an environment where professionals feel compelled to chemically enhance their performance to survive.
Personal stories of pharmaceutical dependency
Mark Moran’s Prescription Pathway
Mark Moran’s story illustrates the systemic pressure. Despite lacking a clear ADHD diagnosis, he obtained a prescription to manage a grueling 90-hour workweek. “They gave me a script, and within months, I was hooked,” Moran, 33, told the Journal. “You become dependent on it to work.”
The human cost of this work culture was starkly highlighted by the death of 35-year-old Bank of America investment banker Leo Lukenas III, who passed away from acute coronary artery thrombus after regularly working 100-hour weeks.
Industry response and continued challenges
Following the Lukenas tragedy, some firms like Morgan Stanley have implemented measures to limit junior bankers to 80-hour work weeks. However, the underlying culture of extreme overwork remains largely unchanged.
Trevor Lunsford, a mergers and acquisitions professional, candidly described Adderall as “a very core, integral component of my life.” His typical work schedule involved 20- to 22-hour days, which he claims would have been impossible without pharmaceutical assistance.
Jonah Frey’s experience provides a stark illustration of the medication’s impact. Working as a healthcare investment banker, his days started at 4 a.m. and stretched until 2 a.m. the following day. The intensive Adderall use led to significant side effects:
- Dramatic weight loss of approximately 25 pounds
- Disorientation and loss of temporal awareness
- Complete loss of appetite
“I went in understanding the downside risks,” Frey admitted, “But the reward was making managing director and pulling in a seven-figure salary. I felt that I had to have an edge to make it.”
The report reveals a deeply problematic workplace culture where young professionals feel pressured to compromise their health to advance their careers. The widespread use of stimulants has become a tacit, yet unspoken, survival strategy in the high-stakes world of investment banking.
A system in need of reform
As the financial industry continues to push the boundaries of human endurance, these personal accounts raise critical questions about workplace wellness, mental health, and the true cost of professional success.
The story serves as a powerful indictment of an industry that seemingly values productivity over the well-being of its most ambitious young professionals.
